Clinical Solutions Of North Florida Inc Newberry, FL - 32669

Clinical Solutions Of North Florida Inc is categorized under Medical Labs in Newberry, FL and active since 2001.

Clinical Solutions Of North Florida Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.

If you are seeking more information, feel free to contact Stanley Pardo at the company’s single location by writing to 25430 Sw 16th Avenue, Newberry, Florida FL 32669 or by phoning (352) 472-6633. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Clinical Solutions Of North Florida Inc
Contact Person: Stanley Pardo
Address: 25430 Sw 16th Avenue, Newberry, Florida 32669
Phone Number: (352) 472-6633
Annual Revenue (USD): $100.000 to $499.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 621511
Share This Business:

Clinical Solutions Of North Florida Inc was started in 2001 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Stanley Pardo for inquiries that concern Clinical Solutions Of North Florida Inc by calling the company number (352) 472-6633, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Solutions Of North Florida Inc can be found at the coordinates 29.638117,-82.611366 as well as the street address 25430 Sw 16th Avenue in Newberry, Florida 32669.

For its online presence, you may visit Clinical Solutions Of North Florida Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.